CAPPED BONUSZERTIFIKAT - FRESENIUS MEDICAL CARE Stock

Certificat

DE000PC2GJE4

Market Closed - Boerse Frankfurt Warrants 15:40:18 2024-05-24 EDT
50.53 EUR +1.08% Intraday chart for CAPPED BONUSZERTIFIKAT - FRESENIUS MEDICAL CARE
Current month+3.91%
1 month+4.70%
Date Price Change
24-05-24 50.52 +1.06%
24-05-23 49.99 -0.54%
24-05-22 50.26 -0.63%
24-05-21 50.58 -0.71%
24-05-20 50.94 +0.33%

Real-time Boerse Frankfurt Warrants

Last update May 24, 2024 at 03:40 pm

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC2GJE
ISINDE000PC2GJE4
Date issued 2023-12-19
Strike 54
Maturity 2024-12-20 (209 Days)
Parity 1 : 1
Emission price 41.08
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 51.37
Lowest since issue 41.54
Spread 0.22
Spread %0.43%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.16%
Consensus